References
- Pape U-F, Berndt U, Müller-Nordhorn J et al. Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours. Endocr Relat Cancer. 2008 Dec;15(4):1083-1097. PubMed | Google Scholar
- .Bosman FT, Carneiro F, Hruban RH et al. WHO classification of tumours of the digestive System. Fourth Edition. Accessed October 14, 2017
- Ohmoto A, Rokutan H, Yachida S. Pancreatic neuroendocrine neoplasms: basic biology, current treatment strategies and prospects for the future. Int J Mol Sci. 2017 Jan 13;18(1). pii: E14. PubMed | Google Scholar
- Khan M, Luong T, Watkins J et al. A comparison of
Ki-67 and mitotic count as prognostic markers for metastatic pancreatic
and midgut neuroendocrine neoplasms. Br J Cancer. 2013 May 14;108(9):1838-1845. PubMed | Google
Scholar
- Fesinmeyer MD, Austin MA, Li CI et al. Differences in survival by histologic type of pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1766-1773. PubMed | Google Scholar
- Halfdanarson T, Rabe K, Rubin J, Petersen G. Pancreatic endocrine tumors (PETs): Incidence and recent trend
toward improved survival. Journal of Clinical Oncology.
2007 June; 25(18) suppl: 4584-4584. Google
Scholar